Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$7.2M |
| 2 |
Alibaba
BABA
|
+$7.15M |
| 3 |
Accenture
ACN
|
+$6.96M |
| 4 |
FL
Foot Locker
FL
|
+$6.31M |
| 5 |
Procter & Gamble
PG
|
+$4.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$7.91M |
| 2 |
Nike
NKE
|
+$7.89M |
| 3 |
Apple
AAPL
|
+$6.97M |
| 4 |
Mondelez International
MDLZ
|
+$5.33M |
| 5 |
Danaher
DHR
|
+$4.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.29% |
| 2 | Consumer Discretionary | 21.31% |
| 3 | Healthcare | 12.92% |
| 4 | Industrials | 9.02% |
| 5 | Consumer Staples | 8.43% |
Similar funds
Bayesian Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Bayesian Capital Management held 876 positions worth $521M, up 6.7% from $488M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Bayesian Capital Management withdrew a net $31.4M in Q1 2019, closing 349 positions and reducing 155 holdings. Its most notable exit was Nike, an estimated $7.89M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Micron Technology worth $7.71M.
- Bayesian Capital Management's largest Q1 2019 buy was Micron Technology: 186,500 shares worth $7.71M.
- Bayesian Capital Management added most to Procter & Gamble in Q1 2019, an estimated $4.82M increase.
- Bayesian Capital Management's biggest Q1 2019 reduction was Microsoft, cutting an estimated $7.91M.
- Bayesian Capital Management fully exited Nike in Q1 2019, selling an estimated $7.89M.
- Bayesian Capital Management's ten largest holdings make up 12% of its $521M portfolio in Q1 2019.
- Bayesian Capital Management opened 284 new positions and closed 349 in Q1 2019.
- Bayesian Capital Management's portfolio value rose 6.7% quarter-over-quarter to $521M.
Based on Bayesian Capital Management's 13F filing for Q1 2019, filed 14 May 2019.